Metabolomics of Extracellular Vesicles: A Future Promise of Multiple Clinical Applications
YaLi Wu,WenJuan Chen,Mengfei Guo,Qi Tan,E Zhou,Jingjing Deng,Minglei Li,Jiangbin Chen,Zimo Yang,Yang Jin
DOI: https://doi.org/10.2147/ijn.s390378
IF: 7.033
2022-12-07
International Journal of Nanomedicine
Abstract:YaLi Wu, 1, &ast WenJuan Chen, 1, &ast Mengfei Guo, 1 Qi Tan, 1 E Zhou, 1 Jingjing Deng, 1 Minglei Li, 1 Jiangbin Chen, 1 Zimo Yang, 1 Yang Jin 1– 3 1 Department of Respiratory and Critical Care Medicine, Key Laboratory of Respiratory Diseases of National Health Commission, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 3 Clinical Research Center for Major Respiratory Diseases in Hubei Province, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yang Jin, Department of Respiratory and Critical Care Medicine, Key Laboratory of Pulmonary Diseases of Health Ministry, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China, Email Extracellular vesicles (EVs) can contain DNA, RNA, proteins and metabolic molecules from primary origins; they are coated with a phospholipid bilayer membrane and released by cells into the extracellular matrix. EVs can be obtained from various body liquids, including the blood, saliva, cerebrospinal fluid, and urine. As has been proved, EVs-mediated transfer of biologically active molecules is crucial for various physiological and pathological processes. Extensive investigations have already begun to explore the diagnosis and prognosis potentials for EVs. Furthermore, research has continued to recognize the critical role of nucleic acids and proteins in EVs. However, our understanding of the comprehensive effects of metabolites in these nanoparticles is currently limited and in its infancy. Therefore, we have attempted to summarize the recent research into the metabolomics of EVs in relation to potential clinical applications and discuss the problems and challenges that have occurred, to provide more guidance for the future development in this field. Keywords: extracellular vesicles, metabolomics, metabolites, clinical application Extracellular vesicles (EVs) are membrane-bound lipid nanovesicles secreted by various cells. 1 While the EVs from different cells display similar physical characteristics, they are highly heterogeneous. 2 EVs can usually be roughly subdivided into microvesicles (MVs), exosomes, and apoptotic bodies, and they differ from each other in size, shape, formation process, and biological functions. 3 Originally, EVs were thought as a trash accumulator for cells, as a way to deal with unneeded components. Up to now, it has been gradually demonstrated that EVs also regulate physiological and pathological responses. Extensive studies have recognized the significance of EVs in information transfer and cell-to-cell communication, such as tumor development, 4 immune responses, 5 and cell apoptosis. 6 EVs are composed of thousands of nucleic acids, proteins, and lipids, 7 and their surfaces are composed of a sophisticated lipid bilayer which can protect their inner biomolecules. 8 They can also pass through the blood–brain barrier, which characterizes their value in initiation and development of neurological diseases (Figure 1). 9 Figure 1 The structure and content of EVs. EVs have a complex composition of nucleic acids (DNA, RNA), protein, metabolites and amino acid. 7 Some proteins are on the surface of the particles and used as markers for EVs, such as CD9, CD63, CD81. 1–3 Additionally, EVs surface also include cell adhesion proteins, cell‐type‐specific proteins, and lipid. 4–9 Created with BioRender.com. The role of nucleic acids and proteins in EV-mediated communication has been widely reported. 10–12 Considering the similarity of the cargoes in EVs and primary cells, EVs can function as biomarkers for the diagnosis of disease and disease stages. 13 In the era of tissue biopsy as the gold standard for cancer diagnosis, EVs can be utilized as novel and non-invasive tools to enable early diagnosis and timely monitoring. 14 Increasingly, researchers have designed EVs as targeted carriers to package drugs, miRNAs, and proteins, and thus facilitate the remarkable and precise treatment of diseases. 15 In laboratory testing, metabolomics focuses on small-molecule metabolites that are less than or equal to 1500 Da in biological specimens, in -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology